Sangamo Therapeutics, INC: 1 tracked 2026 layoff event(s), 51 workers counted, highest AI score 4.
AI score 4 (80% interval 3–4) · evidence grade D · CA · Pharma / Chemicals
Stated reason: On June 18, 2026, the Company’s Board of Directors approved a restructuring of the Company’s operations and a corresponding reduction in workforce. The Company expects the restructuring to result in the elimination of approximately 51 roles in the United States, or approximately 40% of the Company’s workforce. The Company notified employees affected by restructuring on June 22, 2026. The Company will continue to adva…
Why 4: Plant, store or site closure · Drivers: contrary evidence −0.6, industry AI exposure +0.5, role AI exposure +0.2
Signals: attribution 0.0, primary 0.0, exec 0.0, role exposure 0.761, industry exposure 0.712, AI investment 0.0, contrary 0.4 · named roles: Computer and Information Systems Managers, General and Operations Managers
Headcount basis: 8-K text · WARN: 51 workers at 2 site notice(s)
Company AI financials (AI spending, revenue, earnings-call AI mentions) are coming soon to this page.
